Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension (Q43193916)

15 November 2017

Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension (English)

1 reference

15 November 2017

0 references

7

1 reference

15 November 2017

Roberto Fogari

1

1 reference

15 November 2017

Annalisa Zoppi

2

1 reference

15 November 2017

Luca Corradi

3

1 reference

15 November 2017

Paola Preti

4

1 reference

15 November 2017

Amedeo Mugellini

5

1 reference

15 November 2017

Pierangelo Lazzari

6

1 reference

15 November 2017

15 January 2010

1 reference

15 November 2017

Hypertension Research

1 reference

15 November 2017

33

1 reference

15 November 2017

3

1 reference

15 November 2017

236-242

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.220

15 November 2017

0 references

cites work

Obesity as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Abdominal obesity is associated with increased risk of acute coronary events in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Obesity rising to alarming levels around the world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Prevalence of overweight and obesity in the United States, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

The disease burden associated with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

New developments in mechanisms of obesity-induced hypertension: role of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Obesity and vascular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

The effects of weight reduction on blood pressure in 301 obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Effect of body weight loss on blood pressure after 6 years of follow-up in stage 1 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Insulin resistance and systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Insulin Secretion in Obesity and Diabetes: An Illustrative Case

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Effects of weight reduction on arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Increased adipose angiotensinogen gene expression in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Hormonal Correlates of Weight Loss Associated with Blood Pressure Reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Weight loss and the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Caloric restriction lowers blood pressure in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Interactions between leptin and the human sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Role of leptin in the regulation of body fluid volume and pressures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Relationship between changes in serum leptin levels and blood pressure after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

Epidemiology, risks and pathogenesis of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Role of catecholamines in hypotensive response to dieting

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Effect of long-term changes in diet and exercise on plasma leptin concentrations

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.220

7 January 2021

Identifiers

DOI

10.1038/HR.2009.220

1 reference

15 November 2017

1 reference